Novel bisbenzamidines and bisbenzimidazolines as noncompetitive NMDA receptor antagonists

Bioorganic & Medicinal Chemistry Letters
1999.0

Abstract

A series of novel bisbenzamidines and bisbenzimidazolines with different linkers connecting the aromatic groups was tested in vitro for NMDA receptor antagonist activity. IC50 values for these compounds ranged from 1.2 to >200 microM. The bisbenzamidine with a homopiperazine ring as the central linker was found to be the most potent NMDA receptor antagonist among all the pentamidine analogues tested so far.

Knowledge Graph

Similar Paper

Novel bisbenzamidines and bisbenzimidazolines as noncompetitive NMDA receptor antagonists
Bioorganic & Medicinal Chemistry Letters 1999.0
Inhibitory effects of pentamidine analogues on spermine stimulated ligand binding to the NMDA receptor complex
Bioorganic & Medicinal Chemistry Letters 1997.0
Pentamidine analogs as inhibitors of [3H]MK-801 and [3H]ifenprodil binding to rat brain NMDA receptors
Bioorganic & Medicinal Chemistry 2015.0
Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia
Bioorganic & Medicinal Chemistry Letters 2004.0
Antitumor and Anti-Pneumocystis Carinii Activities of Novel Bisbenzamidines
Medicinal Chemistry Research 2005.0
Aromatic analogs of arcaine inhibit MK-801 binding to the NMDA receptor
Bioorganic & Medicinal Chemistry Letters 1998.0
Synthesis of N,N'-Substituted Piperazine and Homopiperazine Derivatives with Polyamine-like Actions at N-Methyl-D-aspartate Receptors
Journal of Medicinal Chemistry 1995.0
Parallel Solution-Phase Synthesis of Conformationally Restricted Congeners of Pentamidine and Evaluation of Their Antiplasmodial Activities
Journal of Medicinal Chemistry 2004.0
1,2-Ethane bis-1-amino-4-benzamidine is active against several brain insult and seizure challenges through anti-NMDA mechanisms targeting the 3H-TCP binding site and antioxidant action
European Journal of Medicinal Chemistry 2010.0
Development of highly active anti-Pneumocystisbisbenzamidines: insight into the influence of selected substituents on thein vitroactivity
MedChemComm 2017.0